e pili ana i ka ʻaelike", e like me ka koi o ka mākeke, hui pū ʻo ia i ka hoʻokūkū ma ka mākeke ma kona ʻano kiʻekiʻe a hāʻawi pū i ke kōkua ʻoi aku ka nui a me ke kōkua ʻokoʻa i nā mea kūʻai aku e hoʻomohala iā lākou i lanakila nui.ʻO ka ʻimi ʻana i ka ʻoihana, ʻo ia ka ʻoluʻolu o nā mea kūʻai aku no ka Hoʻolālā kaulana no ka API Raw Material 99% Allopurinol CAS 315-30-0 Ka mālama ʻana i ka Gout, He mau makahiki o ka ʻike hana, ua ʻike mākou i ka mea nui o ka hoʻolako ʻana i nā huahana maikaʻi a me ka ʻoi aku ka maikaʻi ma mua o ke kūʻai aku a ma hope o ke kūʻai aku.
e pili ana i ka ʻaelike", e like me ka koi o ka mākeke, hui pū ʻo ia i ka hoʻokūkū ma ka mākeke ma kona ʻano kiʻekiʻe a hāʻawi pū i ke kōkua ʻoi aku ka nui a me ke kōkua ʻokoʻa i nā mea kūʻai aku e hoʻomohala iā lākou i lanakila nui.ʻO ka hahai ʻana i ka ʻoihana, e ʻoluʻolu nā mea kūʻai akuKina Allopurinol CAS 315-30-0 a me Allopurinol CAS 315-30-0 Mea Hoʻolako, Ke ʻimi nei mākou i nā manawa e hālāwai ai me nā hoa āpau mai ka home a ma waho no ka hui lanakila-lanakila.Manaʻolana mākou e loaʻa ka hui lōʻihi me ʻoukou a pau ma ke kumu o ka pōmaikaʻi like a me ka hoʻomohala maʻamau.
Hoʻohana ʻia ia i nā mea maʻi me ka hyperuricemia mua a me ka lua, ʻoi aku hoʻi i nā mea maʻi me ka hyperuricemia, a me nā mea maʻi me ka renal insufficiency, a me nā mea maʻi me ka gout recurrent a maʻi, a me nā mea maʻi me Hyperuricemia.Hoʻohana ʻia i nā poʻe maʻi me ka nephropathy ʻo Gouty e hōʻoluʻolu i nā hōʻailona a hōʻemi i ka hoʻokumu ʻana o nā pōhaku uric acid renal;nā pōhaku gout;hoʻohana ʻia i nā pōhaku uric acid a me ka maʻi uric acid.
Hiki i kēia huahana a me kāna mau metabolites ke kāohi i ka xanthine oxidase, no laila ʻaʻole hiki ke hoʻololi ʻia ka hypoxanthine a me ka xanthine i ka uric acid, ʻo ia hoʻi, ua hoʻemi ʻia ka synthesis o ka uric acid, a laila e hōʻemi ana i ka neʻe o ka uric acid i loko o ke koko a hoʻemi i ka ʻike o ka urate i loko. nā iwi, nā hui a me nā puʻupaʻa, nā lāʻau lapaʻau e hiki ke hoʻopaʻa i ka synthesis o ka waika uric.Hiki i kēia huahana ke pale i ka hana o nā enzymes lāʻau lapaʻau ate.
(1) .Hoʻohana pū ʻia ka hyperuricemia mua a me ke kula lua, ʻoi aku ka nui o ka nui o ka uric acid no ka hyperuricemia me ka lawa ʻole o ka renal;
(2) .No ka mālama ʻana i ka gout, kūpono no ka gout mau a i ʻole ka maʻi gout.No nā poʻe maʻi me ka nephropathy gouty, hiki iā ia ke hōʻoluʻolu i nā hōʻailona a hoʻemi i ka hoʻokumu ʻana o nā pōhaku uric acid i loko o nā puʻupaʻa;
(3) .Tophi;
(4) .Hoʻohana ʻia no nā pōhaku uric acid a me (a) uric acid nephropathy.
Kūlana:usp42
ʻIke:98-102%
waho:Pauda keʻokeʻo a aneane keʻokeʻo
Pūʻolo:25kg/ʻeke
Loaʻa ka hoʻopau ʻana i ka iwi iwi, hiki ke hoʻoulu i ka pancytopenia, a pono e hoʻopau ʻia ka lāʻau inā pono.E inu nui i ka wai i ka wā o ka lāʻau lapaʻau, a e hoʻokaʻawale i ka mimi a i ʻole ka alkaline e hoʻokuʻu i ka waikawa diuretic.Pono e hoʻohana ʻia kēia huahana ma hope o ka nalo ʻana o ka mumū nui o ka maʻi gouty (maʻamau ma kahi o ʻelua pule ma hope o ka hoʻomaka ʻana).I ka wā o ka lāʻau lapaʻau, pono ke nānā mau ʻia ke kiʻi koko a me ke akepaʻa a me ka hana ʻana.
e pili ana i ka ʻaelike", e like me ka koi o ka mākeke, hui pū ʻo ia i ka hoʻokūkū ma ka mākeke ma kona ʻano kiʻekiʻe a hāʻawi pū i ke kōkua ʻoi aku ka nui a me ke kōkua ʻokoʻa i nā mea kūʻai aku e hoʻomohala iā lākou i lanakila nui.ʻO ka ʻimi ʻana i ka ʻoihana, ʻo ia ka ʻoluʻolu o nā mea kūʻai aku no ka Hoʻolālā kaulana no ka API Raw Material 99% Allopurinol CAS 315-30-0 Ka mālama ʻana i ka Gout, He mau makahiki o ka ʻike hana, ua ʻike mākou i ka mea nui o ka hoʻolako ʻana i nā huahana maikaʻi a me ka ʻoi aku ka maikaʻi ma mua o ke kūʻai aku a ma hope o ke kūʻai aku.
Hoʻolālā kaulana noKina Allopurinol CAS 315-30-0 a me Allopurinol CAS 315-30-0 Mea Hoʻolako, Ke ʻimi nei mākou i nā manawa e hālāwai ai me nā hoa āpau mai ka home a ma waho no ka hui lanakila-lanakila.Manaʻolana mākou e loaʻa ka hui lōʻihi me ʻoukou a pau ma ke kumu o ka pōmaikaʻi like a me ka hoʻomohala maʻamau.